This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Pathogenesis

Authoring team

Pathogenesis of intrahepatic cholestasis of pregnancy is unclear

  • multiple factors probably interact with a genetic predisposition to alter the membrane composition of bile ducts and hepatocytes and increase their sensitivity to sex steroids
  • a family history (autosomal dominant and possibly X linked) is commonly associated with haplotypes HLA-B8 and HLA-Bw16
  • hormonal factors are implicated because intrahepatic cholestasis worsens with multiple pregnancies and can recur with menstruation and oestrogen treatment (3)
  • occurs more commonly in mothers of patients with rare, inborn cholestatic syndromes such as progressive familial intrahepatic cholestasis type 3 or recurrent familial intrahepatic cholestasis, both related to dysfunction of biliary transporters (4)

Reference:

  1. Walker KF et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD000493. DOI: 10.1002/14651858.CD000493.pub3.
  2. Royal College of Obstetricians and Gynaecologists (April 2011). Guideline No. 43 - Obstetric cholestasis.
  3. BMJ 1994;309:1243-1244
  4. BMJ. 2002 Jan 19;324(7330):123-4

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.